ondansetron has been researched along with Ureteral Diseases in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Ureteral Diseases: Pathological processes involving the URETERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diclofenac sodium was effective as a primary pain reliever in 24 (77." | 2.70 | Ondansetron versus diclofenac sodium in the treatment of acute ureteral colic: a double blind controlled trial. ( Canda, E; Coşkun, F; Ergene, U; Fowler, J; Kirkali, Z; Pekdemir, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ergene, U | 1 |
| Pekdemir, M | 1 |
| Canda, E | 1 |
| Kirkali, Z | 1 |
| Fowler, J | 1 |
| Coşkun, F | 1 |
1 trial available for ondansetron and Ureteral Diseases
| Article | Year |
|---|---|
Ondansetron versus diclofenac sodium in the treatment of acute ureteral colic: a double blind controlled trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colic; Diclo | 2001 |